Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Biotech Surge Sends Averill to the Top of February’s Market Winners Stephen Taub GMO to Investors: Stop Gambling With Your Assets James Comtois II Communities on Global Markets Sponsored by CME Group